Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,591.90
(
0.54%
)
US TECH 100
23,492.22
(
0.57%
)
Dow Jones
46,429.49
(
0.66%
)
Brent Oil
98.74
(
2.32%
)
Bitcoin
70,964.97
(
0.63%
)
News Focus
News Focus
Post# of 257285
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122810
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 229979

Saturday, 03/28/2020 3:09:46 PM

Saturday, March 28, 2020 3:09:46 PM

Post# of 257285
Re: Pneumococcus vaccination

The recommended course for adults is Prevnar 13 followed by Pneumovax with ≥8 weeks in between (to not overwhelm the immune system).

PFE and MRK are each developing pneumococcus vaccines to supersede Prevnar 13 and Pneumovax, respectively, but these products probably won’t be on the market until 2021. Please see #msg-154439687 for related discussion.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today